Circulating Interleukin-4 Is Associated with a Systemic T Cell Response against Tumor-Associated Antigens in Treatment-Naïve Patients with Resectable Non-Small-Cell Lung Cancer

Circulating Interleukin-4 Is Associated with a Systemic T Cell Response against Tumor-Associated Antigens in Treatment-Naïve Patients with Resectable Non-Small-Cell Lung Cancer

Spontaneous T cell responses to tumor-associated antigens (TAs) in the peripheral blood of patients with non-small-cell lung cancer (NSCLC) may be relevant for postoperative survival. However, the conditions underlying these T cell responses remain unclear. We quantified the levels of 27 cytokines i...

Full description

Bibliographic Details
Main Authors: Seyer Safi, Yoshikane Yamauchi, Hans Hoffmann, Wilko Weichert, Philipp J. Jost, Hauke Winter, Thomas Muley, Philipp Beckhove
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Cancers
Subjects:
lung cancer
cytokine
T cells
immunotherapy
Online Access:https://www.mdpi.com/2072-6694/12/12/3496

Internet

https://www.mdpi.com/2072-6694/12/12/3496

Similar Items